Inventor · disambiguated record
Chinping Chng
Also filed as: CHNG CHINPING
16 granted patents·13 pending applications·18 citations·filing 2018–2025
89Inventor score
Top patents by PatentIndex Score
29 records- 0195US11236311B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·3 cites·25 claims
- 0293US11970722B2Engineered acid alpha-glucosidase variantsCODEXIS INC·Filed 2020·Granted Apr 30, 2024·4 cites·39 claims
- 0391US10738286B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Aug 11, 2020·3 cites·22 claims
- 0489US10793841B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Oct 6, 2020·4 cites·26 claims
- 0588US2025027061A1T7 rna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 0687US11427813B2Human alpha-galactosidase variantsCODEXIS INC·Filed 2019·Granted Aug 30, 2022·3 cites·25 claims
- 0786US12071642B2Engineered amylase variantsCODEXIS INC·Filed 2023·Granted Aug 27, 2024·0 cites·21 claims
- 0886US11236312B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·1 cites·10 claims
- 0983US2024384251A1Engineered amylase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1081US12129494B2T7 RNA polymerase variantsCODEXIS INC·Filed 2021·Granted Oct 29, 2024·0 cites·17 claims
- 1179US12497605B2Engineered acid alpha-glucosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Granted Dec 16, 2025·0 cites·20 claims
- 1278US2023295599A1Engineered phenylalanine ammonia lyase polypeptidesCODEXIS INC·Filed 2023·Application pending·0 cites
- 1378US2023295598A1Engineered phenylalanine ammonia lyase polypeptidesCODEXIS INC·Filed 2023·Application pending·0 cites
- 1476US11767519B2Engineered amylase variantsCODEXIS INC·Filed 2021·Granted Sep 26, 2023·0 cites·18 claims
- 1575US12286655B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·0 cites·18 claims
- 1675US2022389464A1Engineered tyrosine ammonia lyaseCODEXIS INC·Filed 2022·Application pending·0 cites
- 1774US2025179460A1Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1872US11421253B2Engineered tyrosine ammonia lyaseCODEXIS INC·Filed 2021·Granted Aug 23, 2022·0 cites·20 claims
- 1972US10900055B2Engineered tyrosine ammonia lyaseCODEXIS INC·Filed 2019·Granted Jan 26, 2021·0 cites·23 claims
- 2072US2024263156A1Engineered lipase variantsNESTLE SA·Filed 2024·Application pending·0 cites
- 2169US11987823B2Engineered lipase variantsNESTLE SA·Filed 2020·Granted May 21, 2024·0 cites·48 claims
- 2269US2021222145A1Engineered phenylalanine ammonia lyase polypeptidesCODEXIS INC·Filed 2021·Application pending·0 cites
- 2368US2025207118A1Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2466US10995329B2Engineered phenylalanine ammonia lyase polypeptidesCODEXIS INC·Filed 2018·Granted May 4, 2021·0 cites·28 claims
- 2565US2024409912A1Engineered protease polypeptidesCODEXIS INC·Filed 2024·Application pending·0 cites
- 2663US11959108B2Engineered protease variantsCODEXIS INC·Filed 2021·Granted Apr 16, 2024·0 cites·39 claims
- 2763US2023279404A1Engineered oxalate decarboxylasesCODEXIS INC·Filed 2023·Application pending·0 cites
- 2860US2021269787A1Human alpha-galactosidase variantsCODEXIS INC·Filed 2021·Application pending·0 cites
- 2950US2021269789A1Engineered branched chain ketoacid decarboxylasesCODEXIS INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →